Showing results (71-80 of 702) with videos related to

Sort By:
Pageof 71
Psychiatry Research|November 1, 1985
Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathologyD Naber, M Albus, H Bürke, et al.
The British Journal of Psychiatry. Supplement|September 1, 1993
Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?W Gaebel, U Frick, W Köpcke, et al.
Polish Journal of Pharmacology|December 14, 2004
Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failureU Keil, A Bonert, C A Marques, et al.
Comprehensive Psychiatry|April 4, 2000
Prodromal states in schizophreniaW Gaebel, M Jänner, N Frommann, et al.
Neurology|January 24, 2002
Frontocortical N-acetylaspartate reduction associated with long-term i.v. heroin useR Haselhorst, K M Dürsteler-MacFarland, K Scheffler, et al.
Der Nervenarzt|May 1, 1997
[Structural magnetic resonance tomography in diagnosis and research of Alzheimer type dementia]H Hampel, S J Teipel, H U Kötter, et al.
European Journal of Histochemistry : EJH|January 11, 2007
Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's diseaseP Brunner, N Sözer-Topcular, R Jockers, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 1, 2006
Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's diseaseC Frey, A Bonert, T Kratzsch, et al.
Praxis|April 25, 2000
[Alzheimer dementia]C Hock, R M Nitsch
Pageof 71